Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs072180039Completed
Randomised, open-label trial of Episil and dexamethasone in stomatitis and head and neck cancer (HNC) (2 arms). Primary endpoint: Effect on pain relief. Started Apr 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs072180039.